Bolkun L, Tynecka M, Wasiluk T, Piszcz J, Starosz A, Grubczak K, et al. A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia. J Clin Med. 2022;11: pubmed publisher

Piantoni S, Regola F, Masneri S, Merletti M, Lowin T, Airo P, et al. Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Beli. Front Pharmacol. 2021;12:666971 pubmed publisher

Robinson T, Abdelhak A, Bose T, Meinl E, Otto M, Zettl U, et al. Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis. Cells. 2020;9: pubmed publisher

Hoffmann F, Kuhn P, Laurent S, Hauck S, Berer K, Wendlinger S, et al. The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity. J Immunol. 2015;194:542-52 pubmed publisher

Thompson S, Jones J, Cox A, Compston D, Coles A. B-cell reconstitution and BAFF after alemtuzumab (Campath-1H) treatment of multiple sclerosis. J Clin Immunol. 2010;30:99-105 pubmed publisher